CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-23 | Virgin Herbert EVP, Research & CSO | Option exercise | +13,750 | $1.53 | $21K | 113,450 |
| 2021-08-23 | Virgin Herbert EVP, Research & CSO | Sale | −13,750 | $50.00 | $688K | 99,700 |
| 2021-08-23 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −13,750 | 271,505 | ||
| 2021-08-19 | SATO VICKI L Director | Sale | −6,129 | $44.36 | $272K | 1,620,833 |
| 2021-08-19 | SATO VICKI L Director | Sale | −9,045 | $45.52 | $412K | 1,611,788 |
| 2021-08-18 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 114,277 |
| 2021-08-18 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $42.23 | $211K | 109,277 |
| 2021-08-18 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 82,591 | ||
| 2021-08-10 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 101,075 |
| 2021-08-10 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $41.00 | $56K | 99,700 |
| 2021-08-10 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 285,255 | ||
| 2021-08-04 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $5.18 | $26K | 114,277 |
| 2021-08-04 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $34.92 | $175K | 109,277 |
| 2021-08-04 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 52,129 | ||
| 2021-07-29 | MORE ROBERT J Director | Sale | −9,322 | $36.63 | $341K | 38,378 |
| 2021-07-29 | MORE ROBERT J Director | Sale | −2,348 | $37.58 | $88K | 36,030 |
| 2021-07-27 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 101,075 |
| 2021-07-27 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $36.72 | $50K | 99,700 |
| 2021-07-27 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 286,630 | ||
| 2021-07-21 | Pang Phillip Chief Medical Officer | Option exercise | +4,630 | $1.58 | $7K | 113,907 |
Page 37 of 54 · 1,063 trades